Form 8-K - Current report:
SEC Accession No. 0001437749-25-009982
Filing Date
2025-03-31
Accepted
2025-03-31 08:04:37
Documents
16
Period of Report
2025-03-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K mnpr20250326_8k.htm   iXBRL 8-K 25564
2 EXHIBIT 99.1 ex_795025.htm EX-99.1 23185
7 monologo.jpg GRAPHIC 3641
  Complete submission text file 0001437749-25-009982.txt   202157

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA mnpr-20250331.xsd EX-101.SCH 3579
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mnpr-20250331_def.xml EX-101.DEF 11807
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE mnpr-20250331_lab.xml EX-101.LAB 15858
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mnpr-20250331_pre.xml EX-101.PRE 12022
18 EXTRACTED XBRL INSTANCE DOCUMENT mnpr20250326_8k_htm.xml XML 2945
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

EIN.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39070 | Film No.: 25788999
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)